Groundbreaking study reveals TR1 cells' crucial role in immune response to malaria, paving way for new vaccines and drugs.

Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering ...

Researchers created a light-powered phagobot that merges macrophage immune activity with optical control, allowing activation ...